Sort   by:  
 Page size 
UnknownClinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.
Not available
S-EPMC5887914 | biostudies-literature
UnknownReal-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study.
Not available
S-EPMC9174390 | biostudies-literature
UnknownEfficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study.
Not available
S-EPMC9205141 | biostudies-literature
UnknownInRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Not available
S-EPMC7136362 | biostudies-literature
UnknownModulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naive people with type 2 diabetes.
Not available
S-EPMC4282751 | biostudies-literature
UnknownContinuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Not available
S-EPMC10100006 | biostudies-literature
UnknownEffectiveness and Safety of Insulin Glargine 300 U/ml in High-Risk Subgroups (Renal Impairment and Older Age ≥ 70 years) of Insulin-Naive People with Type 2 Diabetes: A Post hoc Analysis of Real-World ATOS Study.
Not available
S-EPMC12474787 | biostudies-literature
UnknownThe Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Not available
S-EPMC6593824 | biostudies-literature
UnknownThe SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.
Not available
S-EPMC8518876 | biostudies-literature
UnknownToll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
Not available
S-EPMC3562771 | biostudies-literature
Sort   by:  
 Page size